Clinical Trial Update: NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nab-paclitaxel plus FOLFOX as perioperative chemotherapy for operable oesogastric adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Oesophagogastric Cancer
• Stomach Cancer

Drugs mentioned

• FOLFOX
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Cancer of Stomach | Phase 2 | Status: UNKNOWN